Elsevier

Biotechnology Advances

Volume 35, Issue 6, 1 November 2017, Pages 711-725
Biotechnology Advances

Research review paper
Glycosaminoglycans from marine sources as therapeutic agents

https://doi.org/10.1016/j.biotechadv.2017.07.008Get rights and content

Highlights

  • Marine glycosaminoglycans (GAGs) are different to terrestrial GAGs in terms of molecular weight and sulfation.

  • Sulfated GAGs are the most interesting therapeutic molecules in the marine environment.

  • Squid CS posses antiviral and anti-metastatic activities and improves the properties of materials for cartilage engineering.

  • Octopus and squid CS, shark CS/DS and DS from sea squirts and sea urchins could be valuable in nerve regeneration.

  • Sea cucumber fucosylated CS displays antiviral, anti-metastatic, anticoagulant and anti-inflammatory properties.

Abstract

Glycosaminoglycans (GAGs) in marine animals are different to those of terrestrial organisms, mainly in terms of molecular weight and sulfation. The therapeutic properties of GAGs are related to their ability to interact with proteins, which is very much influenced by sulfation position and patterns. Since currently GAGs cannot be chemically synthesized, they are sourced from natural products, with high intra- but also inter-species variability, in terms of chain length, disaccharide composition and sulfation pattern. Consequently, sulfated GAGs are the most interesting molecules in the marine environment and constitute the focus of the present review. In particular, chondroitin sulfate (CS) appears as the most promising compound. CS-E chains [GlcA-GalNAc(4S,6S)] extracted from squid possess antiviral and anti-metastatic activities and seem to impart signalling properties and improve the mechanical performance of cartilage engineering constructs; Squid CS-E and octopus CS-K [GlcA(3S)-GalNAc(4S)], dermatan sulfate (DS) from sea squirts [-iK units, IdoA(3S)-GalNAc(4S)] and sea urchins [-iE units, IdoA-GalNAc(4S,6S)] and hybrids CS/DS from sharks (-B/iB [GlcA/IdoA(2S)-GalNAc(4S)], -D/iD [GlcA/IdoA(2S)-GalNAc(6S)] and –E/iE units [GlcA/IdoA-GalNAc(4S,6S)]) promote neurite outgrowth and could be valuable materials for nerve regeneration. Also displaying antiviral and anti-metastatic properties, a rare CS with fucosylated branches isolated from sea cucumbers is an anticoagulant and anti-inflammatory agent. In this same line, marine heparin extracted from shrimp and sea squirt has proven anti-inflammatory properties, with the added advantage of decreased risk of bleeding because of its low anticoagulant activity.

Introduction

Glycosaminoglycans (GAGs) are linear polysaccharides ubiquitous in the extracellular matrix (ECM) and the cell surface of most animal tissues, either free or bound to proteins. Once thought mere filling material, GAGs are currently recognized to be involved in a number of functions fundamental for cellular communication, differentiation and growth. Therefore, it is reasonable to conceive these molecules as potential therapeutic agents, some already realized as is the case with heparin, which has been the anticoagulant of choice for decades. Probably the most extensively investigated GAG, new roles of heparin are still presently emerging, which serves to illustrate the potential that GAGs hold.

From the chemical point of view, GAGs are polymers consisting of repeating O-linked disaccharide units. These units are formed by an amino sugar and a uronic acid, except keratan sulfate (KS) which has β-d-galactose (Gal) instead of the uronic acid, linked to N-acetyl α-d-glucosamine (GlcNAc) by alternating β1,4 and β1,3 glycosidic bonds. The amino sugar is in most cases acetylated, except in heparin, and the uronic acid can be either glucuronic acid (GlcA) or its isomer iduronic acid (IdoA) (Fig. 1). GAG chains are in most cases sulfated, except hyaluronan (HA). Sulfation in KS occurs exclusively at position 6 of the galactose and acetylglucosamine rings, whereas other sulphated GAGs display greater diversity in the position of sulfate groups. This diversity is further increased by the epimerization of the uronic acid, leading to a number of different disaccharides, in part responsible for the considerable complexity in GAG chains. Both chondroitin sulfate (CS) and dermatan sulfate (DS) contain the same amino sugar (N-acetyl α-d-galactosamine, GalNAc), but glucuronic acid in CS undergoes epimerization to iduronic acid in DS. Sulfation at different positions and in different grades produces similar disaccharide type units in both CS and DS (Fig. 2).

Both heparin (HEP)/heparan sulfate (HS) and CS share the first biosynthetic step, but with the subsequent addition of N-acetyl glucosamine (GlcNAc) in the first case, instead of GalNAc. This initial disaccharide is later modified by sulfation of the aminosugar, leading to sulfoglucosamine, and epimerization of the iduronic acid. Further sulfation occurs in both the uronic acid and sulfoglucosamine, producing the most negatively charged polymer known in nature (Fig. 3). The degree and type of enzymatic modifications after polymerization lead to structural differences between HS and HEP, the latter being more extensively modified (Sugahara and Kitagawa, 2002). These differences between both polymers are mainly in terms of degree of sulfation and epimerization of the uronic ring. In HEP, the most abundant disaccharide is formed by iduronic acid and N-sulfo-α-d-glucosamine sulfated in positions 2 and 6 respectively, while in HS disaccharide abundance varies in different tissues (Shi and Zaia, 2009). Furthermore, HS chains are segregated into unsulfated and highly sulphated heparin-like domains, producing a fine structure which influences HS interactions with protein ligands (Li and Kusche-Gullberg, 2016, Rabenstein, 2002). In animal tissues, HS is expressed and excreted by most mammalian cells and is widely distributed as proteoglycans in the ECM and at the cell surface. On the other hand, HEP is stored as a glycosylation product of serglycin protein core, non-covalently bound to basic proteases, in cytoplasmatic secretory granules (Rabenstein, 2002).

GAGs can be followed throughout animal evolution, starting from primitive sponges, containing no GAGs, to humans. Along the way, some structures are widely distributed, while others are absent in lower organisms or exist with limited complexity (Yamada et al., 2011). This diversity also reflects in the different evolutionary pathways of marine and terrestrial animals, which have led to rare and sometimes unique GAGs in marine organisms. Not surprisingly, considerable effort has been placed in investigating their therapeutic properties and potential uses.

The therapeutic possibilities of GAGs are based on their effects on coagulation, thrombosis, inflammation, cancer, viral infection and tissue development. In some cases as a safer alternative to established applications, such as the anticoagulant heparin, but also with potential in tissue regeneration and in the development of antiviral and anti-tumour drugs.

The bioactivity and therapeutic properties of GAGs depend on their ability to bind to proteins, which is to a great extent influenced by sulfation (Gulati and Poluri, 2016, Hileman et al., 1998, Soares da Costa et al., 2017). Consequently, the main interest of marine GAGs resides on peculiarities related in most cases to distinct sulfation with different interrelated aspects. First, the relative abundance of sulfated units varies in marine and terrestrial GAGs (Table 1) producing changes in charge density among GAG chains. Second, rare disaccharide units, such as CS-K, are only found in marine animals (Table 1, Fig. 2) (Higashi et al., 2015a, Sugahara et al., 1996). Finally, some marine GAGs show unusual patterns (Chavante et al., 2014), specific sequences of consecutive saccharides. Particular patterns are known to be required for the binding of heparin to antithrombin (Petitou et al., 2003) and fribroblast growth factor (Capila and Linhardt, 2002), and of HS to the herpes simplex virus (Liu et al., 2002, Shukla et al., 1999). However, in most cases interactions between GAGs and proteins are not so specific and seem to be rather influenced by charge density and the presence of particular sulfated units (Li and Kusche-Gullberg, 2016, Yamada and Sugahara, 2008).

In both situations, marine sulfated GAGs add new possibilities to current terrestrial sources and they constitute the focus of the present review, incorporating recent studies using CS/DS and HEP/HS extracted exclusively from marine animals. KS, also sulfated, is found in shark cartilage (Zhang et al., 2005), zebra fish (Souza et al., 2007) and the skin of other teleost fish (Ito et al., 1984, Ralphs and Benjamin, 1992), but to the best of our knowledge, the therapeutic properties of marine KS have not been explored. Finally, hyaluronan is an interesting material in regenerative medicine (Muzzarelli et al., 2012, Prestwich, 2011) which can be isolated from the eyes of fish (Murado et al., 2012). However, marine hyaluronan is not substantially different to terrestrial sources, since lacking sulfate groups it is only defined by its molecular weight. Furthermore, hyaluronan is at present mainly produced by bacteria from the Streptococcus zooepidemicus species (Amado et al., 2016, Vázquez et al., 2009, Vázquez et al., 2010, Vázquez et al., 2015), making its extraction from marine organisms uneconomic. Consequently, KS and hyaluronan are not considered here.

Other polysaccharides from marine origin also show potential as therapeutic agents, including those produced by eukaryotes (alginate, fucoidans, ulvans, carrageenans, chitosan) and prokaryotes (exopolysaccharides and extracellular polymeric substances). However, these compounds lay beyond the scope of the present work and are reviewed elsewhere (Cardoso et al., 2016, Delbarre-Ladrat et al., 2014, Senni et al., 2011, Silva et al., 2012).

Section snippets

Regenerative medicine

GAGs play a pivotal role in the development of new tissue in animals and as a consequence, tissue regeneration strategies have in many cases incorporated GAGs. Regardless of the strategy chosen, it is fundamental to provide an environment with the right properties to allow and spatially direct the growth of cells. GAGs are particularly suited to this purpose through their ability to bind to proteins forming proteoglycans and sequester growth factors, which are central in the control of cell

Anticoagulant activity

Heparin, commercially extracted from bovine and porcine tissues, has been used since the 1930′s as an anticoagulant drug, but safety concerns and increasing demand have spurred interest in finding alternatives. Marine animals could be an alternative, since heparin-like compounds are present in invertebrates, such as echinoderms, ascidians, crustaceans and molluscs. Some invertebrate species contain compounds very similar to mammalian heparin with high affinity for antithrombin, while others are

Antiviral

Extracts from a range of marine organisms have shown antiviral activity in both in vitro and in vivo tests. This activity has been ascribed to a number of molecules, in most cases peptides, glycopeptides and polysaccharides (Cheung et al., 2014, Dang et al., 2015, Vo et al., 2011).

Among GAGs, CS-E from squid cartilage has proven a potent antiviral agent against herpes simplex virus (HSV) (Bergefall et al., 2005), T-cell leukaemia virus type I (Jinno-Oue et al., 2013) and the flavivirus dengue (

Cancer

It is well established that the interaction of cells forming the connective tissue surrounding cancer cells greatly influences tumour growth and cancer progression. Tumour cells release growth factors and cytokines that modify the local environment, which in turn influences the migratory, proliferative and survival capabilities of malignant cells. In this process, the adjacent ECM is remodelled (Afratis et al., 2012).

GAGs are one of the principal components of the ECM, and changes in GAG

Anti-inflammatory

Inflammation is a defensive response of the organism to infection or injury, primary achieved through the movement of white blood cells to the site of damage. GAGs, as part of proteoglycans, are involved in this process by participating in the recruitment of leukocytes in blood vessels and facilitating their migration through the endothelium to the injured or infected tissue. The role of GAGs in inflammation is probably behind the anti-inflammatory effects observed in exogenous sulfated GAGs (

Conclusions

Marine GAGs show wide therapeutic potential in a structure specific manner, as evidenced by the in vitro and in vivo studies included in this review. Table 3 summarizes the information currently available on the relationship of structures of marine GAGs and therapeutic properties.

Although many promising results have been described, translation into clinical trials is to date very limited. Extracts of shark cartilage were given as complementary treatment to patients suffering advanced breast and

Acknowledgements

We are grateful to the following projects for support: 0687 NOVOMAR 1 P (POCTEP Programme, EU), iSEAS LIFE13ENV/ES/000131 (LIFE + Programme, EU) and FCT Portugal for the Investigator grant IF/00373/2014.

References (175)

  • A.S. Brito et al.

    A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential

    Carbohydr. Polym.

    (2014)
  • C.-H. Chang et al.

    Gelatin–chondroitin–hyaluronan tri-copolymer scaffold for cartilage tissue engineering

    Biomaterials

    (2003)
  • S.F. Chavante et al.

    A heparin-like glycosaminoglycan from shrimp containing high levels of 3-O-sulfated d-glucosamine groups in an unusual trisaccharide sequence

    Carbohydr. Res.

    (2014)
  • A.V. Desai et al.

    A phase II trial of TBL12 sea cucumber extract in patients with untreated asymptomatic myeloma

    Blood

    (2014)
  • C.P. Dietrich et al.

    Heparin in molluscs: chemical, enzymatic degradation and 13 C and 1 H NMR spectroscopical evidence for the maintenance of the structure through evolution

    Int. J. Biol. Macromol.

    (1989)
  • C.P. Dietrich et al.

    Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis

    Biochim. Biophys. Acta Gen. Subj.

    (1999)
  • K.J. Frommherz et al.

    Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha 1-proteinase inhibitor

    J. Biol. Chem.

    (1991)
  • R.J. Gilbert et al.

    CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension

    Mol. Cell. Neurosci.

    (2005)
  • A.M. Gomes et al.

    Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion

    J. Biol. Chem.

    (2010)
  • C.C. Griffin et al.

    Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin

    Carbohydr. Res.

    (1995)
  • J.N. Hathcock et al.

    Risk assessment for glucosamine and chondroitin sulfate

    Regul. Toxicol. Pharmacol.

    (2007)
  • K. Higa et al.

    Fundamental biomaterial properties of tough glycosaminoglycan-containing double network hydrogels newly developed using the molecular stent method

    Acta Biomater.

    (2016)
  • K. Higashi et al.

    Functional chondroitin sulfate from Enteroctopus dofleini containing a 3-O-sulfo glucuronic acid residue

    Carbohydr. Polym.

    (2015)
  • M. Hikino et al.

    Oversulfated dermatan sulfate exhibits neurite outgrowth-promoting activity toward embryonic mouse hippocampal neurons: implications of dermatan sulfate in neuritogenesis in the brain

    J. Biol. Chem.

    (2003)
  • X. Hu et al.

    Biological hydrogel synthesized from hyaluronic acid, gelatin and chondroitin sulfate by click chemistry

    Acta Biomater.

    (2011)
  • N. Huang et al.

    The depolymerized fucosylated chondroitin sulfate from sea cucumber potently inhibits HIV replication via interfering with virus entry

    Carbohydr. Res.

    (2013)
  • M. Ito et al.

    Isolation and characterization of an asparagine-linked keratan sulfate from the skin of a marine teleost, Scomber japobicus

    Biochim. Biophys. Acta Gen. Subj.

    (1984)
  • D. Kato et al.

    Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein

    Antivir. Res.

    (2010)
  • D. Kawamura et al.

    Sulfation patterns of exogenous chondroitin sulfate affect chondrogenic differentiation of ATDC5 cells

    J. Orthop. Sci.

    (2014)
  • E. Kim et al.

    Paradoxical effects of chondroitin sulfate-E on Japanese encephalitis viral infection

    Biochem. Biophys. Res. Commun.

    (2011)
  • E.H. Knelson et al.

    Heparan sulfate signaling in cancer

    Trends Biochem. Sci.

    (2014)
  • C.-S. Ko et al.

    Type II collagen-chondroitin sulfate-hyaluronan scaffold cross-linked by genipin for cartilage tissue engineering

    J. Biosci. Bioeng.

    (2009)
  • E.O. Kozlowski et al.

    Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin

    J. Thromb. Haemost.

    (2011)
  • C.-Y. Kuo et al.

    Incorporation of chitosan in biomimetic gelatin/chondroitin-6-sulfate/hyaluronan cryogel for cartilage tissue engineering

    Carbohydr. Polym.

    (2015)
  • T.-J. Lee et al.

    Enhancement of osteogenic and chondrogenic differentiation of human embryonic stem cells by mesodermal lineage induction with BMP-4 and FGF2 treatment

    Biochem. Biophys. Res. Commun.

    (2013)
  • F. Li et al.

    Neuritogenic activity of chondroitin/dermatan sulfate hybrid chains of embryonic pig brain and their mimicry from shark liver: involvement of the pleiotrophin and hepatocyte growth factor signaling pathways

    J. Biol. Chem.

    (2007)
  • F. Li et al.

    Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells

    J. Biol. Chem.

    (2008)
  • J.P. Li et al.

    Chapter six — heparan sulfate: biosynthesis, structure, and function

  • W. Lian et al.

    Anti-HIV-1 activity and structure–activity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope

    Biochim. Biophys. Acta Gen. Subj.

    (2013)
  • U. Lindahl et al.

    Chapter 3 Interactions Between Heparan Sulfate and Proteins—Design and Functional Implications, International Review of Cell and Molecular Biology

    (2009)
  • J. Liu et al.

    Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D

    J. Biol. Chem.

    (2002)
  • X. Liu et al.

    Antithrombotic activities of fucosylated chondroitin sulfates and their depolymerized fragments from two sea cucumbers

    Carbohydr. Polym.

    (2016)
  • F. Maccari et al.

    Structural characterization of chondroitin sulfate from sturgeon bone

    Carbohydr. Res.

    (2010)
  • F. Maccari et al.

    Isolation and structural characterization of chondroitin sulfate from bony fishes

    Carbohydr. Polym.

    (2015)
  • G.F. Medeiros et al.

    Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates

    Biochim. Biophys. Acta Gen. Subj.

    (2000)
  • K. Miyachi et al.

    Syntheses of chondroitin sulfate tetrasaccharide structures containing 4,6-disulfate patterns and analysis of their interaction with glycosaminoglycan-binding protein

    Bioorg. Med. Chem. Lett.

    (2015)
  • S. Mizumoto et al.

    Receptor for Advanced Glycation End products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells

    J. Biol. Chem.

    (2012)
  • P.A.S. Mourão et al.

    Spondyloepiphyseal dysplasia, chondroitin sulfate type: a possible defect of paps — chondroitin sulfate sulfotransferase in humans

    Biochem. Biophys. Res. Commun.

    (1981)
  • A. Mucci et al.

    1 H and 13 C nuclear magnetic resonance identification and characterization of components of chondroitin sulfates of various origin

    Carbohydr. Polym.

    (2000)
  • M. Murado et al.

    Optimization of extraction and purification process of hyaluronic acid from fish eyeball

    Food Bioprod. Process.

    (2012)
  • Cited by (0)

    View full text